Which stocks are moving before the opening bell on Tuesday?
Nexalin Technology Inc NXL
$0.34
▼ -1.23%
($0.00)
🎢 High Beta
📅 Earnings This Week
Open
$0.36
Prev Close
$0.34
Day Range
$0.33 – $0.37
52W Range
$0.31 – $2.00
Market Cap
$7.44M
Beta
4.07
EPS (TTM)
$-0.46
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2022-09-16 |
| Shares Out. | 22,010,000 |
| Website | nexalin.com ↗ |
| Phone | 18322600222 |
| Employees | 8 |
| Revenue | $14,950 |
| Gross Profit | $13,133 |
| Net Income | -$2.1M |
| Free Cash Flow | -$5.3M |
| Total Assets | $3.7M |
| Total Liabilities | $808,364 |
| Equity | $2.9M |
About Nexalin Technology Inc
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the US and China, with China generating the maximum sales.
Nexalin Technology Inc is a publicly traded company under the ticker symbol NXL on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
5 analysts (2026-07-01)